Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Analysis of On-Target and Off-Target Resistance Factors Associated with Gilteritinib Efficacy in Relapsed or Refractory AML Patients with FLT3 Mutations

Blood (2024) 144 (Supplement 1): 6090.

https://doi.org/10.1182/blood-2024-199957

Published: 2024

Journal Articles

Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study

Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, Natsuko Shichiri, So Saotome, Esteban Masuda, Yoshiaki Tomiyama

Blood (2023) 142 (Supplement 1): 2578.

https://doi.org/10.1182/blood-2023-182113

Published: 2023

Journal Articles

Efficacy and Safety of Zanubrutinib in Japanese Patients with Mature B-Cell Malignancies

Blood (2022) 140 (Supplement 1): 3663–3665.

https://doi.org/10.1182/blood-2022-168696

Published: 2022

Journal Articles

Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study

Blood (2022) 140 (Supplement 1): 11244–11245.

https://doi.org/10.1182/blood-2022-169782

Published: 2022

Journal Articles

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study

Blood (2022) 140 (Supplement 1): 6030–6032.

https://doi.org/10.1182/blood-2022-165864

Published: 2022

Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Blood (2022) 140 (Supplement 1): 6690–6692.

https://doi.org/10.1182/blood-2022-157438

Published: 2022

Journal Articles

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Blood (2019) 134 (Supplement_1): 4587.

https://doi.org/10.1182/blood-2019-124634

Published: 2019

Journal Articles

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Blood (2019) 134 (Supplement_1): 4589.

https://doi.org/10.1182/blood-2019-126012

Published: 2019

Journal Articles

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura

Blood (2017) 129 (1): 126–128.

https://doi.org/10.1182/blood-2016-08-734947

Published: 2017

Journal Articles

Significance of Fecal Occult Blood Test Followed By Colonoscopy for Asymptomatic Dasatinib-Induced Hemorrhagic Colitis (CML1501 Study)

Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, MD, Yasuhiko Harada, MD, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura

Blood (2016) 128 (22): 1917.

https://doi.org/10.1182/blood.V128.22.1917.1917

Published: 2016

Journal Articles

PAX5-PML Induces Pro B Acute Lymphoblastic Leukemia in Mice

Naoto Imoto, MD, Shingo Kurahashi, MD PhD, Fumihiko Hayakawa, MD PhD, Takahiko Yasuda, MD PhD, Keiki Sugimoto, Yuki Kojima, MD, Takanobu Morishita, MD, Yuichiro Inagaki, MD, Shinobu Tsuzuki, MD PhD, Tomoki Naoe, MDPhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 887.

https://doi.org/10.1182/blood.V124.21.887.887

Published: 2014

Journal Articles

Impact of Macrophage Activation on Delayed Engraftment Following Allogeneic Hematopoietic Stem Cell Transplantation: Mac Ratio, a New Predictive Index

Naomi Kawashima, MD, Satoshi Nishiwaki, MD, PhD, Seitaro Terakura, MD, PhD, Sonoko Kamoshita, MD, Kyoko Watakabe, MD, Emi Yokohata, MD, Daisuke Koyama, MD, Naoko Shimizu, MD, PhD, Shingo Kurahashi, MD, PhD, Yukiyasu Ozawa, MD, PhD, Masafumi Ito, MD, PhD, Koichi Miyamura, MD, PhD

Blood (2013) 122 (21): 4527.

https://doi.org/10.1182/blood.V122.21.4527.4527

Published: 2013

Journal Articles

A Novel STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition in a Wide Range of Hematopoietic Malignancies without Growth Suppression of Normal Hematopoietic Cells

Fumihiko Hayakawa, MD, PhD, Keiki Sugimoto, Shingo Kurahashi, MD, PhD, Takumi Sumida, DVM, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 577.

https://doi.org/10.1182/blood.V118.21.577.577

Published: 2011

Journal Articles

B Cell Receptor-ERK1/2 Signal Cancels PAX5-Dependent Repression of BLIMP1 Probably Through PAX5 Phosphorylation: A Mechanism of Antigen-Triggering Plasma Cell Differentiation

Takahiko Yasuda, MD, Fumihiko Hayakawa, MD, PhD, Shingo Kurahashi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 1109.

https://doi.org/10.1182/blood.V118.21.1109.1109

Published: 2011

Journal Articles

A Novel Direct STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition In a Wide Range of Hematopoietic Malignancies and Effectively Suppresses the Chemotherapy Resistant Quiescent Cells In Vivo

Fumihiko Hayakawa, MD, PhD, Keiki Sugimoto, Shingo Kurahashi, MD, Hironori Matsuyama, Yasuo Harada, Norikazu Hashimoto, Naoto Ohi, Takeshi Kodama, Takumi Sumida, Tomohiro Kinoshita, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 3277.

https://doi.org/10.1182/blood.V116.21.3277.3277

Published: 2010

Journal Articles

PAX5-PML Acts as a Dual Dominant-Negative Form of PAX5 and PML

Shingo Kurahashi, MD, Fumihiko Hayakawa, MD, PhD, Yasuhiko Miyata, MD, PhD, Yosuke Minami, MD, PhD, Akihiro Abe, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 3227.

https://doi.org/10.1182/blood.V116.21.3227.3227

Published: 2010

Journal Articles

PAX5 Phosphorylation by MAP Kinase Signal Potentially Suppresses PAX5 Function and Might Be a Trigger of the Plasma Cell Differentiation

Takahiko Yasuda, MD, Fumihiko Hayakawa, MD, PhD, Shingo Kurahashi, MD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 3898.

https://doi.org/10.1182/blood.V116.21.3898.3898

Published: 2010

Journal Articles

PAX5-PML Acts as a Dual Dominant-Negative Form of Both PAX5 and PML.

Shingo Kurahashi, MD, Fumihiko Hayakawa, MD, PhD, Yasuhiko Miyata, MD, PhD, Yosuke Minami, MD, PhD, Akihiro Abe, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2009) 114 (22): 3070.

https://doi.org/10.1182/blood.V114.22.3070.3070

Published: 2009

Journal Articles

Predicting Clinical Outcome in Patients with Idiopathic Thrombocytopenic Purpura Based on Bone Marrow Clot CD20 + Lymphocytes.

Shingo Kurahashi, MD, Hiroto Narimatsu, M.D., Masafumi Ito, M.D.,Ph.D, Fumiko Yamamoto, M.D., Akiyo Sawamoto, M.D., Tatsuya Adachi, M.D.,Ph.D., Isamu Sugiura, M.D.,Ph.D.

Blood (2006) 108 (11): 3954.

https://doi.org/10.1182/blood.V108.11.3954.3954

Published: 2006

Journal Articles

Exchange of International Staging System for Durie&Salmon Staging System in Therapeutic Strategy for Multiple Myeloma.

Shingo Kurahashi, MD, Hiroto Narimatsu, MD, Takumi Sugimoto, MD, Isamu Sugiura, MD, PhD

Blood (2005) 106 (11): 5167.

https://doi.org/10.1182/blood.V106.11.5167.5167

Published: 2005

NARROW

Analysis of On-Target and Off-Target Resistance Factors Associated with Gilteritinib Efficacy in Relapsed or Refractory AML Patients with FLT3 Mutations

Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study

Efficacy and Safety of Zanubrutinib in Japanese Patients with Mature B-Cell Malignancies

Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Significance of Fecal Occult Blood Test Followed By Colonoscopy for Asymptomatic Dasatinib-Induced Hemorrhagic Colitis (CML1501 Study)

PAX5-PML Induces Pro B Acute Lymphoblastic Leukemia in Mice

Impact of Macrophage Activation on Delayed Engraftment Following Allogeneic Hematopoietic Stem Cell Transplantation: Mac Ratio, a New Predictive Index

A Novel STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition in a Wide Range of Hematopoietic Malignancies without Growth Suppression of Normal Hematopoietic Cells

B Cell Receptor-ERK1/2 Signal Cancels PAX5-Dependent Repression of BLIMP1 Probably Through PAX5 Phosphorylation: A Mechanism of Antigen-Triggering Plasma Cell Differentiation

A Novel Direct STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition In a Wide Range of Hematopoietic Malignancies and Effectively Suppresses the Chemotherapy Resistant Quiescent Cells In Vivo

PAX5-PML Acts as a Dual Dominant-Negative Form of PAX5 and PML

PAX5 Phosphorylation by MAP Kinase Signal Potentially Suppresses PAX5 Function and Might Be a Trigger of the Plasma Cell Differentiation

PAX5-PML Acts as a Dual Dominant-Negative Form of Both PAX5 and PML.

Predicting Clinical Outcome in Patients with Idiopathic Thrombocytopenic Purpura Based on Bone Marrow Clot CD20 + Lymphocytes.

Exchange of International Staging System for Durie&Salmon Staging System in Therapeutic Strategy for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only